However, as groundbreaking as these therapies are, they also pose unique challenges for the drug development process, particularly regarding quality assurance ... therapy, a form of immunotherapy ...
Specifically, the complaint alleges that the company's Durham, North Carolina facility had significant manufacturing compliance issues, including deficiencies in quality assurance and microbial ...
December 13, 2024) - The law firm of Kirby McInerney LLP reminds investors of the January 17, 2025, deadline to seek the role of lead plaintiff in a federal securities class action that has been filed ...